Table 7:

Subgroup Analyses

Patients that underwent Tricuspid Valve Surgery (n=53)
Variables	Pre-	Post-	p
RV global longitudinal strain, %	−17±3	−19±4	0.04
RV fractional area change, %	31±6	29±10	0.3
RV end-diastolic area, cm2	39±8	33±9	0.02
RV end-systolic area, cm2	28±6	26±8	0.4
RV cardiac index, ml/m2	2.4±0.4	2.9±0.5	0.007
Patients that underwent Cardiac Resynchronization Therapy (n=13)
Variables	Pre-	Post-	p
RV global longitudinal strain, %	−16±4	−18±6	0.1
RV fractional area change, %	27±7	30±11	0.2
RV end-diastolic area, cm2	37±6	34±9	0.3
RV end-systolic area, cm2	26±6	22±7	0.09
RV cardiac index, ml/m2	2.5±0.4	2.8±0.5	0.07
Patients that initiation of heart failure therapy(n=31)
Variables	Pre-	Post-	p
RV global longitudinal strain, %	−17±3	−16±4	0.3
RV fractional area change, %	30±7	31±8	0.4
RV end-diastolic area, cm2	36±7	35±9	0.2
RV end-systolic area, cm2	25±5	25±7	0.6
RV cardiac index, ml/m2	2.5±0.3	2.7±0.6	0.09
Patients that had escalation of heart failure therapy (n=48)
Variables	Pre-	Post-	p
RV global longitudinal strain, %	−18±3	−16±4	0.09
RV fractional area change, %	31±10	28±8	0.4
RV end-diastolic area, cm2	38±9	37±9	0.6
RV end-systolic area, cm2	27±8	26±7	0.6
RV cardiac index, ml/m2	2.4±0.6	2.5±0.7	0.7

RV: right ventricle